BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
251 hedge funds and large institutions have $6.04B invested in bluebird bio in 2018 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 98 increasing their positions, 76 reducing their positions, and 73 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
251
Holders Change
-37
Holders Change %
-12.85%
% of All Funds
5.6%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
37
Increased
98
Reduced
76
Closed
73
Calls
$169M
Puts
$88.3M
Net Calls
+$80.8M
Net Calls Change
+$54.9M
Top Buyers
Top Sellers
1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$137M |
2 |
RG
Redmile Group
San Francisco,
California
|
-$36.8M |
3 |
Bank of New York Mellon
New York
|
-$35.3M |
4 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
-$30.7M |
5 |
AllianceBernstein
Nashville,
Tennessee
|
-$27.9M |